Once Daily
  • Home
  • About
    • Contact
  • Innovations
    • 3D Printing
    • Artificial Intelligence
    • Diagnostics
    • eHealth
    • Genomics & Precision Medicine
    • Health Sensors & Wearables
    • Medtech
    • Smartphone & Voice Apps
    • Telemedicine
    • Virtual Reality
    • Reviews
  • Community
  • 15 Minutes with the Doctor
Follow Us
Community
Once Daily
Once Daily
  • Home
  • About
    • Contact
  • Innovations
    • 3D Printing
    • Artificial Intelligence
    • Diagnostics
    • eHealth
    • Genomics & Precision Medicine
    • Health Sensors & Wearables
    • Medtech
    • Smartphone & Voice Apps
    • Telemedicine
    • Virtual Reality
    • Reviews
  • Community
  • 15 Minutes with the Doctor
  • Genomics & Precision Medicine

Deep Genomics is developing life-changing treatments using AI

  • 23 June 2020
  • Once Daily
Deep Genomics
Location: Canada

Applying artificial intelligence to drug development is quicker and can save money.

According to PhRMA, it takes over ten years on average for a new medication to be developed and costs 2.6 billion on average. Despite this, the chances of the drug reaching the market are slim. The high frequency and high cost of failure are daunting figures for those both developing and needing the treatment.

Deep Genomics is looking to change those figures by reinventing the way we develop new medicines. By using AI, they can greatly reduce the amount of trial and error that goes into drug discovery. Their platform allows researchers to find new drug compounds by assessing their impact on subtle differences in our genetic makeup.

This can help predict which new drugs may be the most effective in humans. These drugs can then form the basis of human trials. As they grow the system with more data, their AI will have an increasing number of drugs and genetic target areas, leading to higher chances of finding treatments for more health conditions.

Along with furthering the development of their AI-powered discovery platform, Deep Genomics is also working towards a treatment for Wilson Disease. They recently had a successful series B round, bringing in $40 million to further their research.

Website: https://www.deepgenomics.com/
Email: contact@deepgenomics.com
Image: Deep Genomics

Previous Article
Fitness AI - App
  • Smartphone & Voice Apps

FitnessAI is an iOS app that uses artificial intelligence to generate workouts

  • 22 June 2020
  • Once Daily
Read More
Next Article
e-skin MEVA - Xenoma
  • Health Sensors & Wearables

Xenoma has developed a revolutionary wearable in the form of smart apparel

  • 24 June 2020
  • Once Daily
Read More

Join our network of founders, healthcare professionals, investors and
many others with access to our community only content.



Your privacy is important to us. We hate SPAM and promise to keep your email address safe. By clicking Sign up, you are agreeing to our terms of use.

© Copyright Once Daily. All Rights Reserved.
  • About
  • Privacy
  • Terms

Input your search keywords and press Enter.

Register now to join like-minded
people who are using technology
to redefine healthcare






Your privacy is important to us. We hate SPAM and promise to keep your email address safe. By clicking Sign up, you are agreeing to our terms of use.